Literature DB >> 7252655

Unsuccessful treatment of phenylketonuria with tyrosine.

M L Batshaw, D Valle, S P Bessman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7252655     DOI： 10.1016/s0022-3476(81)80985-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  4 in total

1.  Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU).

Authors:  Cary O Harding; Shelley R Winn; K Michael Gibson; Erland Arning; Teodoro Bottiglieri; Markus Grompe
Journal:  J Inherit Metab Dis       Date:  2014-02-03       Impact factor: 4.982

Review 2.  Phenylketonuria: tyrosine beyond the phenylalanine-restricted diet.

Authors:  F J van Spronsen; P G Smit; R Koch
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

3.  Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.

Authors:  Shelley R Winn; Tanja Scherer; Beat Thöny; Ming Ying; Aurora Martinez; Sydney Weber; Jacob Raber; Cary O Harding
Journal:  Mol Genet Metab       Date:  2017-10-19       Impact factor: 4.797

Review 4.  Phenylketonuria.

Authors:  Francjan J van Spronsen; Nenad Blau; Cary Harding; Alberto Burlina; Nicola Longo; Annet M Bosch
Journal:  Nat Rev Dis Primers       Date:  2021-05-20       Impact factor: 52.329
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.